Member Info for IvorHunch

I am an investor here and also great Western Mining GWMO which is developing a tungsten asset in Nevada. It's looking very promising with drilling starting next week. A good punt at 3.7p, marketcap still tiny.

I took another modest tranche of shares this morning having been reading up further about the company. I am impressed with the management - Ed Loye and Gemma Cryan in particular who both been involved in successful companies which have made shareholders good money. I also like the very low marketcap which gives scope for a substantial riser in the sp. Of course it's a gamble, but hopefully an informed gamble.

I agree. I suspect the plan is to prove the resource, its size and quality, and then put the company up for sale. The new directors are from the City rather than from a mining background and interested in the capital value rather than future income. I would imagine they have a 2 year horizon, although very good drilling results could see action before then.

You are being both fair and reasonable 36800, and it's certain that a poor RNS would knock the shares at least in the short term. Hopefully the long-term results will be positive. My issue is whether rampers and de-rampers actually have any great effect on the share price - I've always thought their influence to be greatly exaggerated. In my case I have never been influenced either way by rampers although I am influenced by posters who are genuinely knowledgeable

I am sure that all you say is correct - and is also public knowledge. My point is that with all this going on, it's surprising that the share price has not reacted. Don't forget that we did get to nearly 8p in May 2021 when ALGW was much smaller and had no positive broker notes to support it.
Maybe it's just that any form of speculative share, however well researched, is unpopular in this current market. We cannot call it a bear market because the FTSE is near its all time high. It's market that is suspicious of anything speculative.

Despite a very positive broker's note and despite reported shortage of stock over the last few days, the share price remains stuck sub 3p. In recent months it looks as if 3p has become a resistance level. It's difficult to see what is going to get the share price to move substantially upwards.

400,000 shares might sound like a lot, but they are only worth £20,800 or so, hardly a massive investment. I would need to see a buy of this size repeated many times to start thinking of stake building going on.

Similar to my story - 1.5p and up to 17p. I have been kicking myself for not selling at 17 or even 10p on the way down and re-investing at 3p, but I genuinely believed in ITX's prospects and was reluctant to sell. I admit that I'm an idiot, but maybe with time.......

A very balanced report with no exaggerations and no unrealistic forecasts. It makes a sound case for ITX and acknowledges that progress could be fairly slow in the short term. A prediction of 12p by Y/E 2022 is not unreasonable which is still well below the 17p high of 2021. And yet despite a thorough report, the sp has fallen today. FinnCap need to stimulate some real interest in ITX otherwise the sp will not reach their prediction.

I have been in RUA since the Aortech days and am very impressed by the management and by the technology. It has developed a number of potentially highly profitable products and the commercialisation will start early next year. The company has acquired the factory next to its present site for the expected expansion of production and research. Its Marketcap is still around £30 million which is far too low for a company with this potential. Its brokers value it at between £4-5 and although I never trust house brokers' estimates, I think the share price at 140p is fat too low. It's worth reading the present update as well as looking at its technology in some depth.

I was also underwhelmed - in fact I don't think I learnt anything new today. The three main areas of sales have already been discussed and were highlighted at the presentation last year. In the past JS has mentioned packaging, surface coatings, paints as areas of interest, but nothing about them today other than a passing reference to packaging. JS seemed less upbeat than usual, but maybe Covid issues have created new problems . I wondered why he cannot mention the significant and 'important' institutional investor? Most companies are pleased to announce institutional support.
So a rather downbeat and repetitive performance overall.

I do agree. I've been on board for quite a while, since the Aortech days, and am up about x3 on my original purchase. The company is moving forward steadily and later this year and in 2022 the commercial potential will be revealed. Its brokers predict EV of 520p and I would certainly hope for 400p per share by the end of 2022. It's got several vital products which will generate real income.

The problem with most of incubators or investment vehicles is that they have tiny percentage holdings in their investee companies, often so small that it's difficult to see how they can ever make a real killing. What is so interesting with TERN is the size of its holdings as a percentage of the investee companies shares.
I was in Vela, but it did nothing. It's apparently changed direction, but I'm still not keen. ANIC is maybe more interesting but I held Fastforward Innovations which Jim Mellon also set up and it did very little. Mellon is the force behind ANIC and admittedly it has done better than FFWD.
So TERN is not easily replicated and is 'almost unique' (contradiction in terms) on AIM.

As I've said on this board on several occasions - it's virtually impossible to value Tern. There are too many unknowns and too many ways of valuing the individual companies. That's why it's such an interesting investment!

I've looked at DMTR but currently hold PYC, TRX, C4XD (could be big), RENE, EVG ( a bit doubtful) and RUA

Very good comment Antelope and exactly as I see it. The sharp fall has been caused by punters who went mad as the price rocketed and now want out. The true value of Tern will ultimately prevail and I am convinced it is well north of today's price, and well above the historic 7p or so quoted by the board before recent developments.

It's a classic proof that patience can pay off. I bought between March 2019 and July 2020 and also suffered a few worries, but I was convinced that ultimately ITX would come right. My mistakes in the past have often been either panicking or selling too soon - I hate to admit that I amassed a good holding of ITM but sold out far too soon. I currently have a number of shares in the pharma sector which will need 2-4 years to come right.

Welcome Panino. Yes this is a fairly rational and sensible board. I am hoping for 20p by the year end based on good figures for the first half, probably announced mid-late July. But it's not just about past performance, rather news of future developments which could drive the sp. In addition to the huge list of products which are currently using ITX there could be news about packaging, paint, surface coatings and construction. There should be new contracts over the next 6 months possibly with some major names involved. I have a good holding bought at 2p and have no intention of top slicing as I think we are only just embarking on an exciting period for ITX.

Useless comment. You cannot even get the marketcap right - it's £57 million not £19 million. As regards the 'content' of your post, if that's what it can be called, you obviously fail to consider the future potential of ITX. Do some research before posting.

I think Itaconix ITX could do something like Tern. It's already up from under 2p to 10p but still very cheap. It produces bio-polymers based on itaconic acids which could be game changing with enormous 'green' applications - replacing detergents, acrylics in paint, industrial coatings, construction applications, replacing some plastics and much more. It has significant partners - Croda, Neuryon, Palmolive etc.